Anacor Completes Enrollment in AN2728 Phase 2b Trial in Psoriasis

Published March 21, 2011

Anacor completes enrollment in AN2728 Phase 2b trial in psoriasis
Anacor Pharmaceuticals announced today that it has completed enrollment in its Phase 2b trial of AN2728, a topical anti-inflammatory product candidate for the treatment of psoriasis. Psoriasis is a chronic inflammatory skin disease that affects approximately 7.5 million people in the United States and over 100 million people worldwide.
Read more on News-Medical-Net

Family of Dead Mexican Migrant Sues U.S.
A wrongful death lawsuit against the U.S. federal government charges that a Mexican man was beaten by immigration agents before one of them fired a stun gun several times as he lie on the ground.
Read more on Officer.com

Family of dead Mexican migrant sues US government
A wrongful death lawsuit against the federal government charges that a Mexican man was beaten by immigration agents before one of them fired a stun gun several times as he lie on the ground.
Read more on Boston Globe